Biolevate S.A.S
Latest round
- Series A
Last raised
- Sep 2026
Total raised
- $31M
Investors
- 6
About Biolevate S.A.S
S operates as a provider of AI-powered platform solutions that accelerate healthcare advancements to pharmaceutical, MedTech, and cosmetics industries, focusing on regulatory compliance and data integrity. The company offers a suite of advanced solutions intended for the pharmaceutical, MedTech, and cosmetics industries, focusing on harnessing ethical AI to drive healthcare innovation. Their flagship products include automated data extraction tools, predictive analytics, and centralized project management systems, all intended to improve compliance, security, and operational efficiency. These solutions target a diverse client base that includes pharmaceutical companies, MedTech firms, and cosmetic manufacturers, aiming to simplify processes like regulatory compliance and data management. Biolevate’s tools are deployed in various geographical markets, including North America and Europe, addressing the stringent demands of these industries for accuracy and transparency in their operations. Biolevate operates primarily on a B2B model, providing subscription-based services and partnerships with clients across multiple sectors. Revenue generation occurs through the licensing of their AI-driven tools and solutions, with clients typically engaging in annual contracts that ensure ongoing access to software updates and support.
Who invested in Biolevate S.A.S
6 investors across 2 rounds
See all investors in Biolevate S.A.S
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Biolevate S.A.S
Who invested in Biolevate S.A.S?
Biolevate S.A.S has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biolevate S.A.S raised?
Biolevate S.A.S has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Biolevate S.A.S last raise money?
Biolevate S.A.S's most recent round on record is a Series A, in Sep 2026.
What does Biolevate S.A.S do?
S operates as a provider of AI-powered platform solutions that accelerate healthcare advancements to pharmaceutical, MedTech, and cosmetics industries, focusing on regulatory compliance and data integrity.
Where is Biolevate S.A.S headquartered?
Biolevate S.A.S is headquartered in France.
Which VCs invest in companies like Biolevate S.A.S?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back healthcare it companies at Biolevate S.A.S's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like Biolevate S.A.S? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.